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Abstract
Aims/hypothesis The aim of this study was to investigate
whether moderate alcohol consumption increases plasma
high molecular weight (HMW) adiponectin and/or muscle
oxidative capacity.
Materials and methods Eleven lean (BMI 18–25 kg/m
2)
and eight overweight (BMI ≥27 kg/m
2) men consumed
100 ml whisky (∼32 g alcohol) or water daily for 4 weeks
in a randomised, controlled, crossover trial. After each
treatment period, muscle biopsies and fasting blood
samples were collected.
Results Adiponectin concentrations increased (p<0.001) by
12.5% after 4 weeks of moderate alcohol consumption.
Moderate alcohol consumption tended to increase HMW
adiponectin by 57% (p=0.07) and medium molecular weight
adiponectin by 12.5% (p=0.07), but not low molecular
weight (LMW) adiponectin. Skeletal muscle citrate synthase,
cytochrome c oxidase and β-3-hydroxyacyl coenzyme A
dehydrogenase (β-HAD) activity were not changed after
moderate alcohol consumption, but an interaction between
alcohol consumption and BMI was observed for cytochrome
c oxidase (p=0.072) and citrate synthase (p=0.102) activity.
Among lean men, moderate alcohol consumption tended to
increase cytochrome c oxidase (p=0.08) and citrate synthase
activity (p=0.12) by 23 and 26%, respectively, but not
among overweight men. In particular, plasma HMW
adiponectin correlated positively with activities of skeletal
muscle citrate synthase (r=0.64, p=0.009), cytochrome c
oxidase (p=0.59, p=0.009) and β-HAD (r=0.46, p=0.056),
while such correlation was not present for LMWadiponectin.
Whole-body insulin sensitivity and intramyocellular triacyl-
glycerol content were not affected by moderate alcohol
consumption.
Conclusions/interpretation Moderate alcohol consumption
increases adiponectin concentrations, and in particular
HMW adiponectin. Concentrations of HMW adiponectin








J. W. J. Beulens:H. F. J. Hendriks (*)
TNO Quality of Life, Business Unit Biosciences,
Utrechtseweg 48, 3704 HE Zeist,
P.O. Box 360, 3700 AJ Zeist, The Netherlands
e-mail: henk.hendriks@tno.nl
J. W. J. Beulens:F. J. Kok
Department of Human Nutrition, Wageningen University,
Wageningen, The Netherlands
L. J. C. van Loon:M. Pelsers
Department of Movement Sciences, Maastricht University,
Maastricht, The Netherlands
T. Bobbert:J. Spranger




Department of Endocrinology Diabetes and Nutrition,
Charité-University Medical School Berlin,
Berlin, Germany
A. Helander
Alcohol Laboratory, Karolinska Institutet and Karolinska
University Hospital,
Stockholm, SwedenAbbreviations
β-HAD β-3-hydroxyacyl coenzyme A dehydrogenase
HMW high molecular weight
IMTG intramyocellular triacylglycerol
LMW low molecular weight
MMW medium molecular weight
Introduction
Moderate alcohol consumption is associated with a de-
creased risk of type 2 diabetes compared with abstention
[1], which could be explained by improved insulin
sensitivity [2]. The underlying mechanism for this is not
clear, but several pathways may be involved. First, moderate
alcohol consumption increases plasma adiponectin concen-
trations, which could precede changes in insulin sensitivity
[2]. Adiponectin improves insulin sensitivity by increasing
muscle fat oxidation and/or decreasing intramyocellular
triacylglycerols (IMTGs) [3]. Adiponectin is present in
plasma as a trimer, hexamer or high molecular weight
(HMW) form, the latter possibly being the most relevant in
the aetiology of insulin resistance [4]. Second, moderate
alcohol consumption acutely affects energy expenditure,
diet-induced thermogenesis, lipolysis and lipid oxidation
[5]. These changes may result from acetate production from
ethanol, which is converted to acetyl-CoA mainly in
peripheral tissue such as muscle [5]. Such acute changes
could cumulatively affect oxidative capacity and insulin
sensitivity.Thisisthefirsthumanstudytoinvestigatewhether
chronic moderate alcohol consumption affects plasma adipo-
nectin oligomers and muscle oxidative capacity.
Materials and methods
In a randomised, controlled, crossover trial, conducted at
TNO Quality of Life, 19 healthy, moderate-drinking, lean
(BMI 18–25 kg/m
2, n=11) and overweight (BMI ≥27 kg/m
2,
n=8) men (aged 18–40 years), consumed 100 ml whisky
(32 g alcohol per day; Famous Grouse Scotch Whisky,
40% vol, Perth, Scotland) or mineral water (Spa Reine,
Spa, Belgium) daily for 4 weeks. For the last 7 days of
each treatment period the diet was fully controlled, and
treatments were separated by a 2 day wash-out period.
This sample size was sufficient to detect ∼15% difference
of β-3-hydroxyacyl-CoA dehydrogenase (β-HAD) and
citrate synthase activity in this crossover trial and
correlation coefficients of 0.55 or higher with 80% power
and accepting an alpha of 0.05. At the end of each
treatment period, muscle biopsies from the vastus lateralis
muscle were taken to assess β-HAD, cytochrome c
oxidase and citrate synthase activity [6], IMTG [7]a n d
succinate dehydrogenase activity [8]. Fasting blood samples
were collected and an OGTT was performed to calculate
whole-body insulin sensitivity. Subjects gave written
informed consent and the University Medical Center Utrecht
Medical Ethics Committee approved the protocol. The study
was conducted according to the Declaration of Helsinki
(2000) and the International Conference on Harmonisation
Guidelines for Good Clinical Practice. Data were analysed
using the SAS statistical software package (SAS/STAT
version 8, SAS Institute, Cary, NC, USA). Treatment effects
were assessed by ANOVA, using general linear modelling,
with BMI, period, treatment and treatment order included in
the model. Two-sided p values below 0.05 were considered
statistically significant.
Results
Compliance to treatments was good as assessed by
measurements of urinary ethyl glucuronide every 5 days,
showing one negative sample during the whisky-drinking
and no positive samples during the water-drinking period.
Another indication was the 11% increase (p<0.001) of
serum HDL-cholesterol after whisky compared with water
consumption. Table 1 shows results on insulin sensitivity,
adiponectin and muscle enzyme activities. Insulin sensitiv-
ity was not changed after moderate alcohol consumption,
but plasma adiponectin concentrations increased from 7.9±
0.2 mg/l after water to 9.0±0.2 mg/l (means±SEM) after
whisky consumption. Moderate alcohol consumption
tended to increase HMW and medium molecular weight
(MMW) adiponectin, but not low molecular weight (LMW)
adiponectin. Differences in insulin sensitivity and adipo-
nectin and its oligomers tended to be more pronounced
among lean than overweight men (Table 2). Muscle
oxidative capacity measured by β-HAD, cytochrome c
oxidase and citrate synthase activity did not differ between
treatments. A borderline significant interaction between
treatment and BMI was observed for cytochrome c oxidase
(p=0.072) and citrate synthase (p=0.102) activity. Moder-
ate alcohol consumption tended to increase cytochrome c
oxidase (+23.7%; 95% CI −3.9 to +51.2%, p=0.08) and
citrate synthase (+24.7%; 95% CI −7.7 to +57.2%, p=0.11)
activity among lean, but not overweight men (Table 2).
Succinate dehydrogenase activity in mixed muscle fibres
decreased (p=0.03) by 15% after moderate alcohol con-
sumption. IMTGs did not differ, despite a 15–20%
difference between both treatments. These results were not
different for lean and overweight men (Table 2). After
whisky consumption, HMW correlated positively with
activities of citrate synthase (r=0.64, p=0.004), cytochrome
c oxidase (r=0.59, p=0.009) and β-HAD (r=0.46, p=
0.056). Activities of citrate synthase (r=0.44, p=0.07),
Diabetologia (2007) 50:1388–1392 1389Table 1 Insulin sensitivity index, adiponectin oligomer concentrations, HbA1c and enzyme activities after 4 weeks of consumption of whisky or
mineral water in 19 lean or overweight men
Mineral water Whisky % Change p value
Insulin sensitivity index
a 10.6±1.3 9.6±1.3 −9.4 0.61
Adiponectin (mg/l) 7.9±0.2 9.0±0.2 12.5 0.0008
HMW 0.7±0.1 1.1±0.1 57.1 0.074
MMW 4.0±0.2 4.5±0.2 12.5 0.065
LMW 3.2±0.3 3.5±0.3 9.4 0.442
HbA1c (%) 4.9±0.02 4.8±0.02 −2.0 0.023
Muscle β-HAD (mol/μg protein) 4.22±0.48 4.37±0.49 3.6 0.827
Muscle citrate synthase (mol/μg protein) 0.66±0.05 0.75±0.05 13.6 0.262
Muscle cytochrome c oxidase (mol/μg protein) 1.48±0.12 1.67±0.12 12.8 0.262
Intramyocellular triacylglycerols (AU)
Type 1 0.027±0.004 0.022±0.004 −18.5 0.339
Type 2 0.010±0.002 0.008±0.002 −20.0 0.489
Mixed 0.019±0.003 0.016±0.002 −15.8 0.429
Succinate dehydrogenase activity (AU)
Type 1 0.084±0.005 0.075±0.004 −10.7 0.122
Type 2 0.057±0.003 0.052±0.003 −8.8 0.221
Mixed 0.073±0.003 0.062±0.003 −15.1 0.028
Data are presented as means±SEM or %
AU Arbitrary units
aInsulin sensitivity according to Matsuda and DeFronzo [15]
Table 2 Insulin sensitivity index, adiponectin oligomer concentrations, HbA1c and enzyme activities (means±SEM) after 4 weeks of consumption
of whisky or water in lean and overweight subjects









a 13.3±1.9 13.0±1.9 −2.3 0.93 7.8±1.6 4.6±1.6 −41.0 0.21
Adiponectin (mg/l) 8.1±0.3 9.4±0.3 16.1 0.01 7.7±0.2 8.5±0.2 10.4 0.08
HMW 0.8±1.2 1.2±0.2 50.0 0.12 0.8±0.1 0.8±0.1 0 0.62
MMW 4.2±0.3 4.8±0.3 14.3 0.13 3.9±0.2 4.1±0.2 5.1 0.52
LMW 3.2±0.4 3.4±0.4 6.3 0.69 3.1±0.4 3.5±0.4 12.9 0.50
HbA1c (%) 4.9±0.02 4.8±0.02 −2.0 0.04 4.9±0.02 4.9±0.02 0 0.53
Muscle β-HAD (mol/μg protein) 4.67±0.50 5.10±0.45 9.2 0.55 3.46±0.90 3.69±1.01 6.7 0.87
Muscle citrate synthase
(mol/μg protein)
0.73±0.08 0.92±0.07 26.0 0.11 0.60±0.05 0.54±0.06 −10.0 0.51
Muscle cytochrome c
oxidase (mol/μg protein)
1.72±0.15 2.12±0.14 23.3 0.08 1.33±0.13 1.13±0.15 −15.0 0.36
Intramyocellular
triacylglycerols (AU)
Type 1 0.022±0.006 0.016±0.005 −27.3 0.50 0.032±0.006 0.028±0.006 −12.5 0.61
Type 2 0.006±0.002 0.008±0.002 33.3 0.41 0.013±0.003 0.007±0.003 −46.2 0.14
Mixed 0.014±0.004 0.013±0.003 −7.1 0.86 0.024±0.004 0.019±0.004 −20.8 0.40
Succinate dehydrogenase
activity (AU)
Type 1 0.086±0.005 0.080±0.005 −7.0 0.40 0.084±0.009 0.069±0.008 −17.9 0.29
Type 2 0.060±0.005 0.055±0.005 −8.3 0.50 0.054±0.005 0.048±0.004 −11.1 0.34
Mixed 0.076±0.005 0.066±0.005 −13.2 0.16 0.069±0.005 0.057±0.004 −17.4 0.15
Data are presented as means±SEM or %
AU Arbitrary units
aInsulin sensitivity according to Matsuda and DeFronzo [15]
1390 Diabetologia (2007) 50:1388–1392cytochrome c oxidase (r=0.32, p=0.20) and β-HAD (r=
0.44, p=0.07) also tended to correlate with MMW
adiponectin, but not LMW adiponectin. A similar pattern
was observed for correlations of adiponectin oligomers with
HDL-cholesterol (HMW: r=0.55, p=0.014; MMW: r=
0.55, p=0.014; LMW: r=0.21, p=0.38).
Discussion
This study showed that moderate alcohol consumption
increases adiponectin concentrations, consistent with previ-
ous reports [2]. We have now observed that the alcohol-
induced increase of adiponectin may be oligomer specific.
Moderate alcohol consumption increased particularly
HMW adiponectin, MMW adiponectin to a lesser extent,
but not LMW adiponectin. These results are in line with
those of Bobbert et al. [9] showing a similar pattern of
changes in adiponectin oligomers after moderate weight
reduction. Studies with thiazolidinedione or rigorous
weight reduction show similar, but more pronounced results
[10]. HDL-cholesterol concentrations correlated particularly
with HMW adiponectin, as previously shown [9]. We have
now also observed that HMW and MMW adiponectin are
correlated with markers of muscle oxidative capacity, in
line with reports of increased fat oxidation after adiponectin
infusion [3] and a recent study showing that adiponectin
increases muscle oxidative capacity [11]. Our results tend to
confirm these findings and show that these relationships
may be specific to HMW adiponectin. Altogether, this
could provide an underlying mechanism for the proposed
importance of HMW adiponectin in the aetiology of insulin
resistance [4].
Despite this, the alcohol-induced increase of adiponectin
and specifically HMW adiponectin did not affect muscle
oxidative capacity, IMTG content and insulin sensitivity. As
some subtle differences were present, we cannot completely
rule out the hypothesis that changes in IMTG content and/or
oxidative capacity could occur. Although it did not reach
significance, we observed a 15–20% lower IMTG content
after whisky than water consumption, which is of similar
magnitude to that observed for a weight loss and physical
activity intervention [12]. Furthermore, moderate alcohol
consumption tended to increase muscle citrate synthase
activity among lean men, but succinate dehydrogenase
activity declined after moderate alcohol consumption in
mixed muscle fibres. All citric acid cycle and respiratory
chain enzymes are thought to change in parallel to
perturbation [13]. Our findings with citrate synthase and
succinate dehydrogenase, however, are contradictory to this
notion. This could simply be due to the measurement of ex
vivo oxidative capacity or to chance. Alternatively, moderate
alcohol consumption could differentially affect various
enzymes in oxidative pathways such as the citric acid or
glyoxylate cycle as suggested by Kokavec and Crowe [14].
Because acetyl-CoA from ethanol oxidation is generated
independently from activation of pyruvate dehydrogenase
complex, it may not affect the citric acid cycle. Alcohol may
instead affect the glyoxylate cycle that bypasses part of the
citric acid cycle, including succinate dehydrogenase [13, 14].
Strengths of this study are its randomised, controlled
crossover design. We assessed compliance to study treat-
ments several times throughout the study and observed no
significant deviations. It is therefore unlikely that our results
are confounded by diet or lifestyle. Our study was, however,
limited by a slightly small sample size for certain contrasts
such as analyses in subgroups of lean and overweight men
or of IMTG content. Therefore these results may be
somewhat preliminary and need to be confirmed with larger
sample sizes. Second, because insulin sensitivity was not the
primary endpoint of this study, an OGTT was used to assess
insulin sensitivity. However, we used an insulin sensitivity
index that correlates well with the gold standard, the
hyperinsulinaemic–euglycaemic clamp technique [15]. In
addition, our results on insulin sensitivity do not differ from
our previous studies using the clamp technique [2]. We
therefore believe that using this insulin sensitivity index has
not influenced our results to a large extent.
In conclusion, this study shows that 4 weeks of daily
moderate alcohol consumption increases adiponectin con-
centrations and particularly HMW adiponectin concentra-
tions, but does not affect insulin sensitivity and oxidative
capacity. Concentrations of HMW and MMW adiponectin
were positively associated with muscle oxidative capacity.
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